Cargando…
Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
SIMPLE SUMMARY: Research into the immunotherapeutic potential of T cells has predominantly focused on conventional alpha beta (αβ) T cells, which recognize peptide antigens presented by polymorphic major histocompatibility complex (MHC) class I and class II molecules. However, innate-like T cells, s...
Autores principales: | Lee, Derek, Rosenthal, Carl J., Penn, Natalie E., Dunn, Zachary Spencer, Zhou, Yang, Yang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221220/ https://www.ncbi.nlm.nih.gov/pubmed/35740670 http://dx.doi.org/10.3390/cancers14123005 |
Ejemplares similares
-
γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023) -
Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
por: Li, Yan-Ruide, et al.
Publicado: (2021) -
Human γδT-cell subsets and their involvement in tumor immunity
por: Wu, Dang, et al.
Publicado: (2017) -
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015) -
γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)